The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC

PHASE3CompletedINTERVENTIONAL
Enrollment

870

Participants

Timeline

Start Date

October 31, 2003

Conditions
Intermittent ClaudicationPeripheral Vascular Disease
Interventions
DRUG

Niacin Extended Release and Lovastatin Tablets

Trial Locations (26)

17033

Penn State College of Medicine, Hershey

19096

Mainline Health Heart Center, Wynnewood

19115

Radiant Research, Philadelphia

21044

HPV Heart P.A., Columbia

23502

Hampton Roads Center for Clinical Research, Inc., Norfolk

28625

Carolina Pharmaceutical Research, Statesville

31093

Clinical Research Center of Georgia, Warner Robins

34239

Cardiovascular Center of Sarasota, Sarasota

47130

River Cities Cardiology, MPC, Jeffersonville

48341

St. Joseph Mercy-Oakland Research Office, Pontiac

54401

Care Foundation, Inc, Wausau

63104

Saint Louis University, St Louis

73104

COR Clinical Research, Oklahoma City

75246

Clinical Cardiology Research Center, Dallas

77030

Baylor College of Medicine, Houston

78205

Pro Research Group, LLC, San Antonio

80200

University of Colorado Health Sciences Center, Denver

85032

Tatum Ridge Internal Medicine, Phoenix

85251

Scottsdale Cardiovascular Research Institute, LLC, Scottsdale

92083

North County Internal Medicine, Vista

92103

Clinical Research Center of California, San Diego

94304

VA Palo Alto Health Care System, Palo Alto

95819

University of California-Davis; Department of Surgery, Sacramento

95825

Sacramento Heart & Vascular Medical Associates, Sacramento

97219

New Hope Research of Oregon, Portland

06030

University of Connecticut Health Center, Farmington

Sponsors
All Listed Sponsors
lead

Kos Pharmaceuticals

INDUSTRY

NCT00071266 - The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC | Biotech Hunter | Biotech Hunter